IL26, interleukin 26, 55801

N. diseases: 51; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.020 Biomarker disease BEFREE Taken together, our data strongly suggest that our newly developed anti-human IL-26 mAb is a potential therapeutic agent for the treatment of diverse chronic inflammatory diseases including psoriasis. 31397631 2020
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.020 Biomarker disease BEFREE Moreover, similar effects of IL-26 were observed in the murine contact hypersensitivity model, indicating that these effects are not restricted to psoriasis. 30423328 2019